Capturing the complete process of embryonic development
By tracking over 1 million cells, researchers created a detailed map of embryonic development in mice. It could provide development and disease insights.
By tracking over 1 million cells, researchers created a detailed map of embryonic development in mice. It could provide development and disease insights.
Professor Michael Yaffe and six MIT alumni are honored for their outstanding professional achievement and commitment to service.
A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.
A new approach can program these cells inside the body and shows promise against diseases caused by dysfunctional T cells, including lymphoma and autoimmune hepatitis.
Wristband device from Encora Therapeutics started as a project in 2.009, MIT’s iconic product-design class.
MIT researchers developed a handheld system that gently collects living cells from patient samples to aid cancer testing and development of personalized medicines.
MIT researchers show implanted nanoantennas can be activated wirelessly to kill brain cancer cells without damage to healthy tissue.
A new study reveals insights into populations of neurons affected by Huntington’s disease, schizophrenia, addiction, and other disorders.
This discovery points toward new combination strategies against cancer, and may explain the iron buildup seen in disorders such as early-onset Parkinson’s disease.
Researchers explore how a key factor can mitigate or promote tuberculosis transmission.
A new study by Whitehead Institute researchers identifies how the widespread parasite Toxoplasma gondii survives in crowded environments in infected cells, which helps it persist in long-lasting brain cysts.
Shannon Knight, a brain and cognitive sciences PhD candidate and McGovern Institute researcher, focuses on developing a novel gene therapy.
Thomas Levenson’s new book shows how arguments against vaccination reach back to the beginning of the technology itself.
Heiman, who studies neurodegenerative diseases such as Huntington’s and Parkinson’s, will lead the institute beginning July 1.
The adjuvant can help the injectable polio vaccine induce a strong immune response in the GI tract, which is considered critical to eradicating the virus.